Penicillin-binding protein 2x (PBP 2x) Intrinsic penicillin resistance in pneumococci and various other pathogenic bacteria is mediated by the production of low-penicillin-affinity variants of essential high-molecularweight penicillin-binding proteins (PBPs), the target proteins of ,-lactam antibiotics (11,25,30,34). These PBPs are believed to be essential enzymes functioning during late stages of murein biosynthesis. They interact with ,-lactams by enzymatically forming a covalent penicilloyl (cephalosporoyl) complex which is enzymatically inactive. ,3-Lactams are recognized by PBPs because of their structural similarity to substrate molecules (i.e., muropeptides), and inhibitors as well as substrates interact with the same active-site serine (for a review, see reference 8). Therefore, mutations responsible for low affinity must be carefully positioned within the protein in order to still allow for its actual in vivo function.We have recently isolated a series of spontaneous, independent mutants with stepwise increasing resistance to cefotaxime (17). All higher-level-resistance mutants contained low-affinity variants of PBP 2x and, in some cases, of PBP 2a as well. Reduction in the penicillin binding of PBP 2x at ddiferent selection steps was detected when mutants from different mutant families were compared, indicating that the development of resistance does not follow a strictly predetermined pathway.The gene coding for the 750-amino-acid PBP 2x (pbpX) has been sequenced, and the mutations in one of the mutants (C506) have been mapped (18). We have now determined the sequence of mutations that occurred with increasing cefotaxime resistance in one mutant family and analyzed their contribution to resistance development. Furthermore, mutations in the pbpX genes of another four independent mutants, obtained after five or six selection steps, were characterized.* Corresponding author.
MATERIALS AND METHODSBacterial strains, phages, and plasmids. The penicillinsusceptible laboratory strain Streptococcus pneumoniae R6 is an unencapsulated derivative of the Rockefeller University strain R36A (1). The cefotaxime-resistant mutants, all derived from the R6 strain, are independent, spontaneous mutants, as described previously (17). The mutant family C006 is composed of six mutants with increasing levels of resistance, from C106 (first-step isolate) to C606 (sixth-step isolate). Mutants C501, C503, C604, and C505 were obtained after five or six selection steps (indicated by the first digit) in mutant families 1, 3, 4, and 5, respectively (indicated by the last digit).The phages Phagescript SK (Stratagene, San Diego, Calif.) and M13mp8/9 (22) were propagated in Escherichia coli JM103 (21), and derivatives of the plasmids pJDC9 (4) and pR28 (20) were propagated in E. coli DH5. Transformation of S. pneumoniae (32) and of E. coli (3) followed published procedures.Isolation of DNA. Details of the isolation of chromosomal DNA and the preparation of phage and plasmid DNA have been described recently (2, 18).Isolation and sequ...